Cargando…

Beta-Lactams Toxicity in the Intensive Care Unit: An Underestimated Collateral Damage?

Beta-lactams are the most commonly prescribed antimicrobials in intensive care unit (ICU) settings and remain one of the safest antimicrobials prescribed. However, the misdiagnosis of beta-lactam-related adverse events may alter ICU patient management and impact clinical outcomes. To describe the cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roger, Claire, Louart, Benjamin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306322/ https://www.ncbi.nlm.nih.gov/pubmed/34361942 http://dx.doi.org/10.3390/microorganisms9071505

Ejemplares similares

Beta-Lactam Dose Optimisation in the Intensive Care Unit: Targets, Therapeutic Drug Monitoring and Toxicity
por: Legg, Amy, et al.
Publicado: (2023)

Beta-lactam allergy labeling in intensive care units: An observational, retrospective study
por: Leone, Marc, et al.
Publicado: (2021)

Hyperchloremia in Intensive Care Unit Mortality: An Underestimated Fact
por: Shad, Zahid Siddique, et al.
Publicado: (2019)

The Current Status and Future Perspectives of Beta-Lactam Therapeutic Drug Monitoring in Critically Ill Patients
por: Novy, Emmanuel, et al.
Publicado: (2023)

Comparison of acute kidney injury and clinical prognosis of vancomycin monotherapy and combination therapy with beta-lactams in the intensive care unit
por: Kang, Soyoung, et al.
Publicado: (2019)

Beta-lactam dosing during continuous renal replacement therapy: a survey of practices in french intensive care units
por: Matusik, Elodie, et al.
Publicado: (2022)

Outcomes of Beta-Lactam Allergic and Non-Beta-Lactam Allergic Patients with Intra-Abdominal Infection: A Case–Control Study
por: Naciri, Tayma, et al.
Publicado: (2022)

Beta lactam hypersensitivities
por: Azoury, Marie Eliane*, et al.
Publicado: (2014)

Impact of the New Delhi metallo-beta-lactamase on beta-lactam antibiotics
por: Zmarlicka, Monika T, et al.
Publicado: (2015)

THE BETA-LACTAM ANTIBIOTICS: Penicillins and Cephalosporins in Perspective
Publicado: (1980)

Dual beta-lactam treatment: Pros and cons
por: Guerra, Diogo, et al.
Publicado: (2022)

Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA
por: Gonzales, Patrick R., et al.
Publicado: (2015)

Drug allergy in children: focus on beta-lactams and NSAIDs
por: Cravidi, Claudio, et al.
Publicado: (2020)

Streptococcal toxic shock syndrome in the intensive care unit
por: Schmitz, Marylin, et al.
Publicado: (2018)

The occurrence of delirium is severely underestimated by intensivists and intensive care unit nurses during daily ICU care
por: Spronk, P, et al.
Publicado: (2007)

The clinical application of beta-lactam antibiotic therapeutic drug monitoring in the critical care setting
por: Pai Mangalore, Rekha, et al.
Publicado: (2023)

Admission and Discharge Sampling Underestimates Multidrug-Resistant Organism (MDRO) Acquisition in an Intensive Care Unit
por: Sansom, Sarah, et al.
Publicado: (2021)

Herpes simplex and intensive care medicine: an underestimated problem?
por: Camps, K, et al.
Publicado: (1999)

Suspected allergy to Beta-Lactam antibiotics: An infectiological perspective
por: Sunderkötter, Cord
Publicado: (2022)

Cephalosporins as key lead generation beta-lactam antibiotics
por: Lin, Xuemei, et al.
Publicado: (2022)

1805. Safety Outcomes Following Beta-Lactam use in Patients with a Documented Beta-Lactam Allergy
por: Rampersad, Daniel, et al.
Publicado: (2022)

COVID’s collateral damage: likelihood of measles resurgence in the United States
por: Thakur, Mugdha, et al.
Publicado: (2022)

Damage control in the intensive care unit: what should the intensive care physician know and do?
por: Vargas, Mónica, et al.
Publicado: (2021)

Genetic associations in beta-lactam allergy
por: Gueant, Jean-Louis, et al.
Publicado: (2014)

Endopeptidase-Mediated Beta Lactam Tolerance
por: Dörr, Tobias, et al.
Publicado: (2015)

Profile of Enterobacteria Resistant to Beta-Lactams
por: Santos, Andressa Liberal, et al.
Publicado: (2020)

Pazopanib-Induced Alopecia, an Underestimated Toxicity?
por: Biondo, Andrea, et al.
Publicado: (2015)

“Anosmia” the mysterious collateral damage of COVID-19
por: Ahmed, Abdulrahman K., et al.
Publicado: (2022)

Preventing collateral damage
por: Quon, Harry, et al.
Publicado: (2021)

Forestalling collateral damage
por: Samaranayake, L.
Publicado: (2022)

Low dose oral beta-lactamase protects the gut microbiome from oral beta-lactam-mediated damage in dogs
por: Connelly, Sheila, et al.
Publicado: (2019)

'Damage control' in the intensive care unit
por: Guimarães, HP, et al.
Publicado: (2003)

Patients with questionable penicillin (beta-lactam) allergy: Causes and solutions
por: Brockow, Knut, et al.
Publicado: (2022)

The Pharmacokinetics of Beta-Lactam Antibiotics Using Scavenged Samples in Pediatric Intensive Care Patients: The EXPAT Kids Study Protocol
por: Schouwenburg, Stef, et al.
Publicado: (2021)

Continuous beta-lactam infusion in critically ill patients: the clinical evidence
por: Abdul-Aziz, Mohd H, et al.
Publicado: (2012)

Tenascin-C: Exploitation and collateral damage in cancer management
por: Spenlé, Caroline, et al.
Publicado: (2015)

Impaired autophagy: The collateral damage of lysosomal storage disorders
por: Myerowitz, Rachel, et al.
Publicado: (2020)

Beta-lactam hypersensitivity: not always what it seems
por: Andrade, Djanira, et al.
Publicado: (2015)

Use of beta-lactams antibiotics in ICU patients
por: Damas, M-P, et al.
Publicado: (2015)

Approach for delabeling beta-lactam allergy in children
por: Sáenz de Santa María, R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_75te6cv0m5b4csrj8675ue8f5e